المؤلفون: Gregersen I; Research Institute for Internal Medicine Oslo University Hospital Rikshospitalet Oslo Norway.; Institute of Clinical Medicine Faculty of Medicine University of Oslo Norway., Michelsen AE; Research Institute for Internal Medicine Oslo University Hospital Rikshospitalet Oslo Norway.; Institute of Clinical Medicine Faculty of Medicine University of Oslo Norway., Lunde NN; Section of Pharmacology and Pharmaceutical Biosciences Department of Pharmacy University of Oslo Norway., Åkerblom A; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center Uppsala University Uppsala Sweden., Lakic TG; Uppsala Clinical Research Center Uppsala University Uppsala Sweden., Skjelland M; Department of Neurology Oslo University Hospital Rikshospitalet Oslo Norway., Ryeng Skagen K; Department of Neurology Oslo University Hospital Rikshospitalet Oslo Norway., Becker RC; Division of Cardiovascular Health and Disease Heart, Lung and Vascular Institute Academic Health Center Cincinnati OH., Lindbäck J; Uppsala Clinical Research Center Uppsala University Uppsala Sweden., Himmelmann A; AstraZeneca Research and Development Gothenburg Sweden., Solberg R; Section of Pharmacology and Pharmaceutical Biosciences Department of Pharmacy University of Oslo Norway., Johansen HT; Section of Pharmacology and Pharmaceutical Biosciences Department of Pharmacy University of Oslo Norway., James SK; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center Uppsala University Uppsala Sweden., Siegbahn A; Uppsala Clinical Research Center Uppsala University Uppsala Sweden., Storey RF; Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield United Kingdom., Kontny F; Department of Cardiology Stavanger University Hospital Stavanger Norway.; Drammen Heart Center Drammen Norway., Aukrust P; Research Institute for Internal Medicine Oslo University Hospital Rikshospitalet Oslo Norway.; Institute of Clinical Medicine Faculty of Medicine University of Oslo Norway.; Section of Clinical Immunology and Infectious Diseases Oslo University Hospital Rikshospitalet Oslo Norway.; K.G. Jebsen TREC The Faculty of Health Sciences The Arctic University of Tromsø Tromsø Norway., Ueland T; Research Institute for Internal Medicine Oslo University Hospital Rikshospitalet Oslo Norway.; Institute of Clinical Medicine Faculty of Medicine University of Oslo Norway.; K.G. Jebsen TREC The Faculty of Health Sciences The Arctic University of Tromsø Tromsø Norway., Wallentin L; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center Uppsala University Uppsala Sweden., Halvorsen B; Research Institute for Internal Medicine Oslo University Hospital Rikshospitalet Oslo Norway.; Institute of Clinical Medicine Faculty of Medicine University of Oslo Norway.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2020 Sep; Vol. 9 (17), pp. e016360. Date of Electronic Publication: 2020 Aug 15.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Acute Coronary Syndrome/*blood , Acute Coronary Syndrome/*drug therapy , Atherosclerosis/*blood , Cysteine Endopeptidases/*blood, Acute Coronary Syndrome/complications ; Aged ; Atherosclerosis/metabolism ; Case-Control Studies ; Clopidogrel/therapeutic use ; Cysteine Proteases/blood ; Death ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Myocardial Infarction/physiopathology ; Platelet Aggregation Inhibitors/therapeutic use ; Risk Factors ; Stroke/epidemiology ; Stroke/physiopathology ; Ticagrelor/therapeutic use ; Treatment Outcome